To listen to Singapore’s leader, the Bank of England nailed it. The UK central bank’s warning of a tough new era that sent shockwaves through the world of monetary economics resonated in the city-state. The tiny republic that’s staked its survival on the ebbs and flows of global capitalism is girding for a protracted period of slacker growth and a ...

  Investors are waking up to the risk of litigation against the makers of Zantac, once a blockbuster treatment for heartburn. All of a sudden, GSK Plc’s decision to spin off rather than sell its consumer-healthcare business, Haleon Plc, is looking costly. Haleon, which is behind brands like Sensodyne toothpaste and Panadol painkillers, was a joint venture between GSK, the ...

  Just like old times. That’s what it must seem like with the S&P 500 Index up about 15% since mid-June and poised for its fourth consecutive weekly gain, its longest winning streak of the year. Those who question the durability of this rally, given the slowdown in the economy and a Federal Reserve that has doubled down on its ...